Trifarotene Fatty Acid Esters for Low-Irritation Topical Delivery

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing topical retinoids used for treating photoaging and acne cause significant skin irritation and are teratogenic, necessitating the development of derivatives with enhanced efficacy and reduced side effects.

Innovation Solution

Trifarotene fatty acid esters, upon hydrolysis in the skin, release short chain fatty acids like octanoic acid and lauric acid, providing antimicrobial benefits and enhancing penetration, formulated in cosmetically acceptable carriers to treat acne and inhibit photoaging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If topical retinoids are used to treat photoaging and acne, then treatment efficacy is improved, but skin irritation and teratogenicity increase

Engineering Contradiction:

Improvetreatment efficacyVSAvoidskin irritation

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the chemical structure of retinoids by converting them to fatty acid esters, changing their physical and chemical parameters such as lipophilicity and molecular weight. This structural modification allows the compounds to maintain retinoid activity while reducing skin irritation and teratogenicity, as the esterified form is less directly active until hydrolyzed in the skin

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The fatty acid ester acts as an intermediary form that is less irritating than the active retinoid. The ester serves as a prodrug that is hydrolyzed by skin esterases to release the active retinoid, thereby mediating between the need for effective treatment and the need to minimize skin irritation and systemic exposure

Inventive Principle:

Principle #24Intermediary (Mediator)

2Speed

If shorter chain fatty acid esters are used, then penetration enhancement and antimicrobial benefits are improved, but formulation stability may be affected

Engineering Contradiction:

Improvepenetration rateVSAvoidformulation stability

Core Design Contradiction:

SpeedVSStability of the object's composition

Solution Approach 1:

The patent systematically varies the chain length of the fatty acid ester to optimize the balance between penetration enhancement and formulation stability. Shorter chain esters (C6-C10) provide greater penetration enhancement and antimicrobial activity, while the patent selects specific chain lengths to maintain adequate formulation stability, demonstrating parameter optimization to resolve the contradiction

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The trifarotene fatty acid esters effectively reduce signs of photoaging and acne with minimal skin irritation, offering antimicrobial and penetration-enhancing properties.

Implementation Method 1

upon hydrolysis in the skin, the shorter chain esters release short chains fatty acids such as octanoic acid and lauric acid

Methodology Applied

Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS20260060911A1Ester of trifarotene

Publication Date: 2026.03.05 ACTERA INGREDIENTS INC

AI summary

Certain trifarotene fatty acid esters and external, topical skin care compositions containing one or more such compounds are described. In some embodiments, upon hydrolysis in the skin, shorter chain trifarotene fatty acid esters release short chain fatty acids such as octanoic acid and lauric acid, which are known to contribute to penetration enhancement in topical skin delivery. Methods of topically applying the external compositions to the skin of a subject to inhibit or reduce signs of photoaging or acne are also described.